Elizabeth Swisher Discusses Rucaparib's Side Effects for Patients With Ovarian Cancer

Video
Conference|SGO Annual Meeting on Women's Cancer

Elizabeth Swisher, M.D., professor, Department of Medicine, Division of Medical Genetics, University of Washington School of Medicine, Breast and Ovarian Cancer Prevention Program, Seattle Cancer Care Alliance, discusses the side effects of rucaparib in the ARIEL2 trial, for patients with relapsed, platinum-sensitive high-grade ovarian carcinoma.

Elizabeth Swisher, M.D., professor, Department of Medicine, Division of Medical Genetics, University of Washington School of Medicine, Breast and Ovarian Cancer Prevention Program, Seattle Cancer Care Alliance, discusses the side effects of rucaparib in the ARIEL2 trial for patients with relapsed, platinum-sensitive high-grade ovarian carcinoma.

While overall deemed to be well-tolerated, the most common side effects that were experienced by patients were nausea, vomiting, fatigue, and anemia. These side effects get significantly better over the course of treatment.

Related Videos
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Woman with dark brown hair and pink lipstick wearing a light pink blouse with a light brown blazer. Patients should have conversations with their providers about treatments after receiving diagnoses.
Man in a navy suit with a purple tie. Dr. Saby George talks to CURE about how treatment with Opdivo could mitigate disparities in patients with kidney cancer.
Dr. Kim in an interview with CURE
Dr. Barzi in an interview with CURE
Related Content
image of "hope" in a pair of hands.

Shining Through Cancer and Fear

April 7th 2024
Article

Even after surgery and chemotherapy, I make sure to shine through cancer and any fear that stares at me.

Read More

cancer horizons logo: a white microphone on a navy blue background

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

March 11th 2024
Podcast

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.

Listen

Illustration of a woman with short gray hair, thing rectangular glasses and pink lipstick.

A Strange New World of Cancer Research Has a Cost

March 19th 2024
Article

My genetic testing covered 648 gene variants. Of course, researchers only know the significance of a fraction of those variants.

Read More

cancer horizons image for podcast

Conference Highlights from the 2023 ASH Annual Meeting

December 14th 2023
Podcast

CURE® recently covered the 2023 American Society of Hematology Annual Meeting. In case you missed it, here is some news that came out of the conference that patients should know about.

Listen

Experimental cancer vaccine vial for immunization against Cancer disease. Doctor with vial of the Cancer vaccine | Image credit: © angellodeco - © stock.adobe.com

Ovarian Cancer Vaccine Trial Gets FDA Clearance To Proceed

March 6th 2024
Article

The Food and Drug Administration green lit a first-in-human phase 1 clinical study of Innocell, a vaccine for the treatment of stage 3 and 4 ovarian cancer.

Read More

female doctor in white coat with clipboard talking to patient

Cancer the Second Time Around

February 20th 2024
Article

After my treatment ended for triple-negative breast cancer, I thought I was done with cancer — and then I was diagnosed with ovarian cancer.

Read More